Although the primary focus of this podcast is prostate health, we will occasionally break from that topic to cover other important subjects related to urology. Today, we have a special bonus episode about bladder cancer.

We are happy to have Dr. Abhi Solanki joining us on the podcast today! Dr. Solanki is a Radiation Oncologist. After completing his residency training in Radiation Oncology at the University of Chicago Pritzker School of Medicine, he joined the faculty at Loyola University Medical Center, where he is currently an Associate Professor in the Department of Radiation Oncology. He also serves as Quality Medical Director in the department and the Chair of the Genitourinary Cancer Disease Committee at the Cancer Center at Loyola. Much of his clinical focus includes treating genitourinary cancers, including prostate, bladder, kidney, and testicular cancer.  

In this episode, we review some of the basics of bladder cancer. We then get you up to speed with all you need to know about bladder-preserving Trimodality Therapy as an alternative to radical bladder removal for muscle-invasive bladder cancer. Stay tuned for more!

Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation.

Show highlights:

• Dr. Solanki discusses the signs and symptoms of bladder cancer.
• Some factors that could increase an individual’s risk of developing bladder cancer.
• Dr. Sloanki explains how a diagnosis of bladder typically gets made.
• The treatment options that are available for individuals with a new diagnosis of muscle-invasive bladder cancer.
• Dr. Solanki discusses the current increase in the utilization of Trimodality Therapy.
• Dr. Solanki describes the best candidates for Trimodal Therapy.
• The risks, benefits, and side-effects of Trimodality Therapy, as a treatment for bladder cancer.
• The options that patients have for a bladder tumor recurrence after undergoing Trimodality Therapy.
• Dr. Solanki encourages people to educate themselves about all the available options before going down any treatment path. 

 

Links:

Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd 

Get your free What To Expect Guide (or find the link here, on our podcast website)  

Join our Facebook group 

Follow Dr. Pohlman on Twitter and Instagram 

Go to the Prostate Health Academy to sign up for the wait-list for our bonus video content. 

You can access Dr. Pohlman’s free mini webinar, where he discusses his top three tips to promote men’s prostate health, longevity, and quality of life here.